Exciting new Part the Cloud updates

Part the Cloud | Diversifying the research pipeline | Accelerating research through trials into practice

Part the Cloud has raised $65 million since 2012

Part the Cloud has surpassed another major milestone. Since its inception, PTC has raised more than $65 million for Alzheimer’s research thanks to our generous supporters and community.

Top researchers tout the impact of Part the Cloud

Part the Cloud has an extensive application and review process before grants are awarded and projects are officially funded. Each application undergoes a rigorous peer review process from top experts in the field in order to propel innovative research forward. One reviewer provides his perspective on how Part the Cloud accelerates progress.

"This program's proposals really knocks innovation out of the ballpark by exploring truly novel mechanisms. Many proposals are way outside the 'amyloid' box, and I think this is exactly what you were hoping for in PTC."

  • -Paul B. Rosenberg, MD, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine

Part the Cloud in the News

The future of Alzheimer’s treatments may lie in what already exists for other conditions. Part the Cloud, in partnership with the Alzheimer’s Association and Bill Gates, is supporting 60 new treatment trials that target inflammation, metabolism and other biological factors. Many of these trials seek to find answers in drugs that already exist. Read more about two Part the Cloud projects featured in USA Today, “Beyond Aduhelm: Why experts have never felt more optimistic about Alzheimer's treatments” (subscription required). Read more on the Science Hub app.

The 2021 Part the Cloud Gala was featured in numerous outlets including Haute Living San Francisco, The Almanac, Nob Hill Gazette, and SanFrancisco Magazine. Learn more.

KNBR Podcast recently honored Part the Cloud as part of the Forever Young Foundation’s Hero of the Week. Learn more.

Congress agrees on Alzheimer’s research funding increase

Congressional leaders announced a $289 million increase for Alzheimer’s and dementia research funding at the National Institutes of Health (NIH) for fiscal year 2022, including $25 million to fund and implement the BOLD Infrastructure for Alzheimer’s Act. Throughout the past year, the Alzheimer’s Association; the Alzheimer’s Impact Movement, a separately incorporated advocacy affiliate; and its dedicated volunteers advocated for this increase.


To fund Alzheimer's research with the highest probability of slowing, stopping or ultimately curing Alzheimer's disease.